Announcements Trials
Browse Landscape

Phase

Phase 2 1

Status

Completed 1

Sponsor Class

NIH 1

Study Type

Interventional 1

Sponsor

Cancer Type

Sarcoma 1

Conditions

Carcinoma, Hepatocellular 66Carcinoma, Renal Cell 38Liver Neoplasms 20Neoplasm Metastasis 17Carcinoma, Non-Small-Cell Lung 16Neoplasms 15Breast Neoplasms 15Melanoma 13Thyroid Neoplasms 10Leukemia, Myeloid, Acute 10Sarcoma 9Lung Neoplasms 8Kidney Neoplasms 8Prostatic Neoplasms 7Ovarian Neoplasms 7Urinary Bladder Neoplasms 6Pancreatic Neoplasms 6Glioblastoma 6Brain Neoplasms 6Colorectal Neoplasms 5Carcinoma, Medullary 5Thyroid Carcinoma, Anaplastic 4Stomach Neoplasms 4Rectal Neoplasms 4Gliosarcoma 4Gallbladder Neoplasms 4Colonic Neoplasms 4Breast Neoplasms, Male 4Thyroid Diseases 3Thyroid Cancer, Papillary 3

Interventions

vatalanib 1soblidotin 1romidepsin 1perifosine 1exatecan 1brostallicin 1Vincristine 1Trabectedin 1Temozolomide 1Sunitinib 1Sorafenib 1Radiotherapy, Intensity-Modulated 1Radiotherapy 1Polymerase Chain Reaction 1Peripheral Blood Stem Cell Transplantation 1Neoadjuvant Therapy 1Magnetic Resonance Spectroscopy 1Ifosfamide 1Gene Expression Profiling 1Filgrastim 1Etoposide 1Epirubicin 1Doxorubicin 1Dactinomycin 1Cyclophosphamide 1Carboplatin 1Blotting, Western 1Bevacizumab 1

Date Range

30 days90 days1 yearAll

Options

Has results Has announcements

Clinical Trials

1 trials
RecentStart dateEnrollment
Phase 2 × Hemangiopericytoma, Malignant × Sorafenib × Clear all
NCT00217620 2014-05-15

S0505 Sorafenib in Treating Patients With Advanced Soft Tissue Sarcomas

National Cancer Institute (NCI)

Phase 2 Completed
51 enrolled 9 charts
Sarcoma

Hemangiopericytoma, Malignant, Hemangiosarcoma, Leiomyosarcoma, Liposarcoma, Sarcoma

Data powered by HemOnc (CC BY 4.0) Colophon âš¡